Reverse Vessel Remodeling But Not Coronary Plaque Regression Could Predict Future Cardiovascular Events in ACS Patients With Intensive Statin Therapy : The Extended JAPAN-ACS Study

この論文にアクセスする

この論文をさがす

著者

    • DAIDA Hiroyuki
    • Department of Cardiology, Juntendo University School of Medicine
    • MORIMOTO Takeshi
    • Center for General Internal Medicine and Emergency Care, Kinki University School of Medicine
    • HIRO Takafumi
    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine
    • KIMURA Takeshi
    • Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
    • YAMAGISHI Masakazu
    • Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine
    • KIMURA Kazuo
    • Division of Cardiology, Yokohama City University Medical Center
    • HIRAYAMA Atsushi
    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine
    • MATSUZAKI Masunori
    • Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine

抄録

<b><i>Background:</i></b> The JAPAN-ACS study demonstrated that statins significantly reduced coronary plaque volume in patients with acute coronary syndrome (ACS). The clinical implications of plaque regression for clinical outcomes in ACS patients has not been established. The Extended JAPAN-ACS study was conducted to evaluate the relationship between coronary plaque regression and long-term clinical outcome, and to explore the factors associated with cardiovascular events. <b><i>Methods and Results:</i></b> Patients with intravascular ultrasound (IVUS) data at both enrollment and follow-up in the JAPAN-ACS study were enrolled and observed for at least 3 years. Patients were divided into lesser and greater coronary plaque regression groups. The primary endpoint was defined as a composite of the following events: cardiovascular death, nonfatal myocardial infarction, nonfatal cerebral infarction, and unstable angina. The median value of the percent change in plaque volume, 18.0%, was used as a cutoff point. There were 4 primary events (3.4%) in the lesser regression group, and 2 events (1.7%) in the greater regression group (P=0.4). Cumulative secondary cardiovascular events did not differ between the 2 groups. Multivariate analysis identified the high-density lipoprotein cholesterol (HDL-C) at baseline and the % change of the external elastic membrane volume as independent risk factors of cardiovascular events. <b><i>Conclusions:</i></b> Coronary plaque regression induced by an intensive statin regimen did not predict future cardiovascular events in ACS patients. Rather, the baseline HDL-C level and reverse vessel remodeling might serve as predictors for cardiovascular events. (<i>Circ J</i> 2012; <b>76:</b> 825-832)<br>

収録刊行物

  • Circulation journal : official journal of the Japanese Circulation Society

    Circulation journal : official journal of the Japanese Circulation Society 76(4), 825-832, 2012-03-25

    一般社団法人 日本循環器学会

参考文献:  20件中 1-20件 を表示

被引用文献:  1件中 1-1件 を表示

各種コード

  • NII論文ID(NAID)
    10030130972
  • NII書誌ID(NCID)
    AA11591968
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    13469843
  • データ提供元
    CJP書誌  CJP引用  J-STAGE 
ページトップへ